特应性皮炎全身治疗的相对疗效
该系统综述通过检索Medline、Ovid和Embase,纳入41项关于成人和儿童特应性皮炎全身治疗疗效的随机对照试验。结果显示度普利尤单抗和环孢素在改善湿疹面积和严重度指数及特应性皮炎评分方面有持续改善,lebrikizumab和tralokinumab的2期试验有效但需3期试验,儿童患者中环孢素改善临床严重度幅度最大。
要点
- 度普利尤单抗和环孢素在改善特应性皮炎临床严重度方面证据最强。
- lebrikizumab和tralokinumab的2期试验显示有效,需3期试验进一步验证。
- 儿童患者中环孢素改善临床严重度幅度最大,生物制剂在儿童中无疗效报告。
核心结论
- 对于重度特应性皮炎的治疗,目前度普利尤单抗和环孢素在改善临床疾病严重度方面证据最强。
- 需要进一步研究以确定生物制剂的长期安全性和疗效。
研究设计与样本
- 系统文献综述,检索Medline、Ovid和Embase,纳入关于成人和儿童特应性皮炎全身治疗疗效的随机对照试验,最终分析纳入41项研究。
主要发现
- 度普利尤单抗和环孢素报告了湿疹面积和严重度指数及特应性皮炎评分的持续改善。
- lebrikizumab和tralokinumab的2期临床试验有效,需3期试验进一步验证。
- 尚无研究报告生物制剂在儿童患者中的疗效;环孢素在该组中改善临床严重度幅度最大。
局限性
- 缺乏良好对照的比较研究使得治疗之间的直接比较困难。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systemic medications are often required for severe atopic dermatitis (AD) refractory to topical therapies. Biologic medications are a recent advancement in the field and a comparison with standard systemic approaches would be beneficial. OBJECTIVE: To compare efficacies of systemic therapies for the treatment of AD. METHODS: A systematic literature review was performed using Medline, Ovid, and Embase. Randomized controlled trials looking at the efficacy of systemic treatments for AD in adults and children were included. RESULTS: A total of 41 studies met criteria and were included in our final analysis. Consistent improvements in Eczema Area and Severity Index and Scoring Atopic Dermatitis were reported with dupilumab and cyclosporine. Phase 2 clinical trials for lebrikizumab and tralokinumab were effective and would benefit from phase 3 trials. No study reported efficacy of biologic medications in pediatric patients; however, cyclosporine improved clinical severity by the greatest amount in this group. LIMITATIONS: A lack of well controlled comparison studies make direct comparisons between the treatments difficult. CONCLUSION: For treatment of severe AD, the strongest evidence currently exists for dupilumab and cyclosporine at improving clinical disease severity. Further research is required to determine long-term safety and efficacy of biologic medications.
引用
- Seger EW, Wechter T, Strowd L, et al. Relative efficacy of systemic treatments for atopic dermatitis. J Am Acad Dermatol. 2018. PMID: 30296535. doi:10.1016/j.jaad.2018.09.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。